NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
BioSentinel: An Adaptable Platform for Studying the Biological Effects of Deep Space RadiationNASA's BioSentinel mission is a 6U nanosatellite with autonomous life support that will utilize the budding yeast Saccharomyces cerevisiae to study the DNA damage response to the deep space radiation environment. BioSentinel is planned to launch in 2019 as a secondary payload on the Space Launch System's first Exploration Mission (EM-1), and will undergo a lunar fly-by and enter heliocentric orbit after deployment. As the first biological mission beyond Low Earth Orbit (LEO) in nearly half a century, this mission will help fill critical gaps in knowledge about the effects of uniquely composed, chronic, low-flux deep space radiation on biological systems. Yeast is well-suited for this mission due to its desiccation tolerance and space-flight heritage. As a eukaryotic model organism, it also serves as a robust analog for human cells. Data gathered on this mission will thus inform us of the hazards involved in long-duration human exploration in deep space, and the protections necessary to mitigate them. Due to its low-cost, flexible and advanced technology, the 4U BioSensor payload contained within the nanosatellite is adaptable to other model microorganisms, exploration platforms and environments relevant to human exploration, such as the ISS, the Lunar Orbital Platform - Gateway and future lunar landers. In order to query the DNA damage response to deep space radiation, BioSentinel contains a wild type yeast strain as a positive control, and a radiation sensitive rad51 mutant strain that is defective for DNA repair. Yeast cells are desiccated in microfluidic cards, and rehydrated with growth medium and metabolic indicator dye at the desired time points during the mission. A thermal control system supports these stasis and growth states, and an optical system continuously measures cell growth and metabolism. An onboard radiation spectrometer and dosimeter allows us to correlate the dose, energy and particle-type of deep space radiation to the biological response. Data received from the deep space biosensor will be compared to control payloads on Earth and the ISS. Ongoing science testing for the BioSentinel project includes optimization for cell viability, desiccation tolerance, and long-term biocompatibility, as well as radiation experiments to understand the sensitivity and responsiveness of cells to varying radiation doses and particle types.
Document ID
20180007383
Acquisition Source
Ames Research Center
Document Type
Presentation
Authors
Tieze, Sofia Massaro
(Blue Marble Space Seattle, WA, United States)
Santa Maria, Sergio R.
(New Mexico Univ. Albuquerque, NM, United States)
Liddell, Lauren
(Logyx, LLC Mountain View, CA, United States)
Bhattacharya, Sharmila
(NASA Ames Research Center Moffett Field, CA, United States)
Date Acquired
November 1, 2018
Publication Date
August 9, 2018
Subject Category
Aerospace Medicine
Report/Patent Number
ARC-E-DAA-TN58841
Funding Number(s)
CONTRACT_GRANT: 80NSSC18M0060
CONTRACT_GRANT: NNA14AB82C
Distribution Limits
Public
Copyright
Public Use Permitted.
Keywords
BioSentinel
Deep space
No Preview Available